Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

CompletedOBSERVATIONAL

Enrollment

134,897

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions

Atrial Fibrillation

Interventions

DRUG

Rivaroxaban (Xarelto)

NOAC, reduced dose

DRUG

Apixaban

NOAC, reduced dose

DRUG

Dabigatran

NOAC, reduced dose

DRUG

Warfarin

VKA

Trial Locations (1)

Many locations, Multiple Locations